A retrospective study of women with severe adenomyosis treated with a six-month course of GnRH agonist following conservative surgery showed that the severity of dysmenorrhea was significantly improved with a decline in the serum level of CA-125 [167]. Here, GNRH1 is linked to adenomyosis.